NCT00188578View on ClinicalTrials.gov

Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Cervix NeoplasmsUterine NeoplasmsVaginal Neoplasms
Interventions
PROCEDURE

Intensity Modulated Radiation Therapy Boost

All patients shall receive a continuous course of IMRT consisting of 25.2 Gy in 14 fractions over 3 weeks

Trial Locations (1)

M5G 2M9

Princess Margaret Hospital, Toronto

All Listed Sponsors
collaborator

Princess Margaret Hospital, Canada

OTHER

lead

University Health Network, Toronto

OTHER

NCT00188578 - Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2) | Biotech Hunter | Biotech Hunter